To elucidate whether MTOR and AKT polymorphisms can serve as risk and/or prognostic markers for GC, we investigated MTOR rs1064261 and AKT rs1130233 polymorphisms in relation to GC risk and their interactions with H. pylori in a case–control study of 1842 subjects. This evidence concerns the gene AKT1 and gastric cancer.